Shopping Cart
Remove All
Your shopping cart is currently empty
NSC16168 is a selective ERCC1-XPF inhibitor that inhibits DNA repair and potentiates the antitumor activity of cisplatin.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $58 | In Stock | In Stock | |
| 5 mg | $139 | In Stock | In Stock | |
| 10 mg | $222 | In Stock | In Stock | |
| 25 mg | $375 | In Stock | In Stock | |
| 50 mg | $552 | In Stock | In Stock | |
| 100 mg | $787 | In Stock | In Stock | |
| 200 mg | $1,070 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $145 | In Stock | In Stock |
| Description | NSC16168 is a selective ERCC1-XPF inhibitor that inhibits DNA repair and potentiates the antitumor activity of cisplatin. |
| Targets&IC50 | ERCC1 XPF:0.42 μM |
| In vitro | NSC16168 is a specific inhibitor of ERCC1-XPF with an IC50 of 0.42 μM. NSC16168 potentiates the antitumor effect of cisplatin on cancer cells in the concentration range of 0-50 μM. [1] |
| In vivo | In the H460 lung cancer xenograft model, NSC16168 was injected intraperitoneally twice a day at a dose of 20 mg/kg and showed significant antitumor effects and synergistically enhanced the efficacy of cisplatin. [1] |
| Synonyms | NSC 16168 |
| Molecular Weight | 473.5 |
| Formula | C17H15NO9S3 |
| Cas No. | 6837-93-0 |
| Smiles | O=S(=O)(O)C=1C=C(OS(=O)(=O)C2=CC=C(C=C2)C)C3=C(N)C=C(C=C3C1)S(=O)(=O)O |
| Relative Density. | 1.5197 g/cm3 (Estimated) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (42.24 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.22 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.